pf-00232798
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2007 (NCT00495677)
Timeline
Indications
Studied for
Mechanism of action
- C-C chemokine receptor type 5ANTAGONIST
CCR5 antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- pf-00232798
- pf-00232798
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01140425 | Phase 1 | Jul 1, 2010 | Pfizer, ViiV Healthcare |
| NCT00495677 | Phase 2 | Jun 1, 2007 | Pfizer |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pfizer | For profit | 2 | 2 | 2 | 2007 |
| ViiV Healthcare | For profit | 1 | 0 | 1 | 2010 |
2 organizations
Page 1 / 1